Accuracy in Copy Number Calling by qPCR and PRT: A Matter of DNA by Fernandez-Jimenez, Nora et al.
Accuracy in Copy Number Calling by qPCR and PRT: A
Matter of DNA
Nora Fernandez-Jimenez
1,2, Ainara Castellanos-Rubio
1,2, Leticia Plaza-Izurieta
1,2, Galder Gutierrez
1,
In ˜aki Irastorza
1,3, Luis Castan ˜o
1,3, Juan Carlos Vitoria
1,3, Jose Ramon Bilbao
1,2*
1Immunogenetics Research Laboratory, Cruces University Hospital, Barakaldo, Basque Country, Spain, 2Department of Genetics, Physical Anthropology and Animal
Physiology, University of the Basque Country, Leioa, Basque Country, Spain, 3Department of Pediatrics, University of the Basque Country, Bilbao, Basque Country, Spain
Abstract
The possible implication of copy number variation (CNV) in the genetic susceptibility to human disease needs to be
assessed using robust methods that can be applied at a population scale. In this report, we analyze the performance of the
two major techniques, quantitative PCR (qPCR) and paralog ratio test (PRT), and investigate the influence of input DNA
amount and template integrity on the reliability of both methods. Analysis of three genes (PRELID1, SYNPO and DEFB4)i na
large sample set showed that both methods are prone to false copy number assignments if sufficient attention is not paid
to DNA concentration and quality. Accurate normalization of samples is essential for reproducible qPCR because it avoids
the effect of differential amplification efficiencies between target and control assays, whereas PRT is generally more
sensitive to template degradation due to the fact that longer amplicons are usually needed to optimize sensitivity and
specificity of paralog sequence PCR. The use of normalized, high quality genomic DNA yields comparable results with both
methods.
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Introduction
Copy number variation (CNV) has emerged as a common
source of genomic diversity in humans and it is thought to affect at
least 12% of the human genome [1]. Rare alterations in gene copy
content identified by robust techniques like comparative genomic
hybridization (CGH) have been implicated in several develop-
mental diseases and cancer, but more common structural variation
of the genome has been proposed to be associated with increased
risk to complex diseases, and there is growing interest in
population screening of CNVs. It is known that CNVs cannot
be efficiently tagged by nearby SNPs because of the possibility of
recurrent mutations and transposition of the duplicated genomic
segments into new genomic locations [2]. Additionally, genetic
association projects that rely on case-control comparisons are
particularly vulnerable to inaccuracies in raw data, and may result
in false positive evidence of association between CNVs and disease
[3]. Thus, direct, reliable methods for CNV assessment that are
applicable to large-scale studies are necessary.
PCR-based methods assign gene copy number values according
to the ratio of test/reference product yields. In the paralog ratio
test (PRT) a single pair of primers is designed to exploit sequence
similarities between elements (often dispersed repeats) present both
in the copy variable unit (the ‘test’ locus) and at another genomic
location that is invariable (the ‘reference’ locus). This strategy
avoids the problems caused by the comparison between the yields
of two dissimilar amplicons that may have different amplification
efficiencies [4]. PRT is indeed a robust, high throughput approach
for the study of common CNV at the population level, but
identification of a suitable paralog for each target gene is time-
consuming (and sometimes impossible) and careful design of
primers is necessary before the actual experiment can be
performed. In turn, quantitative PCR (qPCR) compares threshold
cycles (Ct) between the target gene and an unrelated reference
sequence that does not vary in copy content, to generate DCt
values which are used for CNV calculation. In theory, this is a
straightforward strategy that has been used for large-scale CNV
analysis to detect disease associations, including the b-defensin
cluster and Crohn’s disease [5,6], psoriasis [7] or celiac disease
(CD) [8]. However, the DCt method is highly dependent on the
amplification efficiency of each of the two different assays that are
competing in a single reaction. It has been shown that a 4%
change in amplification efficiency could result in an error of up to
400% in DCt calculation [9] and CNV results obtained by qPCR
have been questioned [10].
In this work, we present qPCR as a simple, fast and reliable
alternative for CNV analysis if normalized amounts of input
template DNA are used. We also investigate the effect of DNA
quality in qPCR and PRT-based CNV analysis and compare the
performance of both methods. For this purpose we selected 3
genes: PRELID1, a gene involved in mitochondrial apoptosis in
human primary Th2 cells [11], SYNPO, which has been shown to
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28910regulate the actin-based shape and motility of dendritic cells [12]
and DEFB4, a gene that takes part in the innate immune response
and is located in the copy number variable b-defensin cluster,
previously associated with several autoimmune diseases [13]. Our
interest in PRELID1 and SYNPO is due to the fact that they map to
putative CNV regions [1] and are potentially implicated in celiac
disease pathogenesis because they are located in a CD linkage
region and show altered expression in active patient mucosa [14].
Methods
Ethics Statement
Human blood samples were collected for immune gene copy
number association studies in celiac disease, after written informed
consent had been obtained from donors or their parents. This
study was approved by the Clinical Trials and Ethics Committee
of Hospital de Cruces.
DNA samples
Genomic DNA was extracted from whole human blood using
Nucleospin Blood DNA extraction kit (Macherey-Nagel, Du ¨ren,
Germany) following the manufacturer’s instructions, and resus-
pended in ddH2O. To prepare the normalized sample set, DNA
was quantified using Quant-it PicoGreen dsDNA reagent
(Invitrogen, Carlsbad, CA) and DNA concentrations were
adjusted to 2.5 ng/ml with a Biomek NX
P Laboratory Automation
Workstation (Beckman Coulter, Fullerton, CA). Non-normalized
samples were resuspended in 50 ml ddH2O, regardless of DNA
concentration. DNA integrity was tested by electrophoresis in 1%
agarose-TAE gels.
Copy number assignment using real time qPCR
Quantitative PCR analysis of PRELID1 and SYNPO gene
content was performed in 400 normalized and 400 non-
normalized DNA samples using commercially available,
predesigned TaqMan Copy Number Assays (Assay IDs:
Hs01090614_cn and Hs00669480_cn for PRELID1 and SYNPO,
respectively, each consisting of a pair of unlabeled primers and a
FAM labeled, MGB probe) and the RNase P Copy Number
Reference Assay, with a VIC-labeled TAMRA probe (all from
Applied Biosystems, Foster City, CA). Experiments were prepared
with the Biomek NX
P automated liquid handler in 384 microwell
plates, and consisted of 10 ml reactions containing 2 ml DNA (from
the normalized or non-normalized sample sets), 5 ml Taqman
Genotyping Master Mix (Applied Biosystems) and 0.5 ml each of
one target gene and reference CNV assay mixes. The PRELID1
qPCR assay was additionally run in 96 poorly preserved DNA
samples, in order to check the impact of DNA quality in copy
number assignment. In the case of DEFB4, qPCR was carried out
in triplicate in 366 normalized genomic DNA samples. Reactions
(10 ml) were prepared in the same manner except that a custom
primer-probe set was used as the target assay, as previously
described [8]. Following the manufacturer’s instructions, all qPCR
reactions were run in triplicate on an ABI 7900HT instrument
(Applied Biosystems) and thermal cycling conditions were 95uC,
10 min followed by 40 cycles of 95uC for 15 s and 60uC for 1 min.
Copy number assignment using paralog ratio test (PRT)
We were not able to design a PRT assay for SYNPO because we
did not find a suitable invariable copy number paralog for this
gene. However, we identified a paralog for PRELID1 in
chromosome 1 (Figure 1). PCR was carried out in 25 ml reactions
with 5 ng of input genomic DNA, 1 mM each primer (forward:
CCAAGGACCTCGCCAGCAA and reverse: 6-FAM -GGCA-
AGTCACCGCACCTCTGT), 0.5 mM each dNTP, 1.25 U Taq
DNA polymerase, 2.5 ml1 0 6 NH4-based BioTaq buffer and
1.5 mM supplementary MgCl2 (all from BIOLINE, London, UK)
in 96 good quality and 96 degraded DNA samples. Amplifications
consisted of 26 cycles of 95uC for 30 s, 59uC for 30 s and 72uC for
1 min, to ensure a detectable product yield without reaching
amplification plateau, followed by a single step of 56uC for 5 min
and 72uC for 20 min, to avoid heteroduplex formation. 4 mlo f
each PCR reaction were added to a digestion mix containing
100 mM NaCl, 50 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT
and 15 U Bcl I restriction enzyme (New England Biolabs, Ipswich,
MA) in order to obtain two FAM-labeled fragments of 299 bp
(PRELID1) and of 169 bp (paralog in chromosome 1) (Figure 1).
After overnight incubation at 50uC, 2 ml of the digestion reaction
were mixed with 10 ml HiDi formamide with ROX-500 marker,
and analyzed by electrophoresis on an ABI3130XL 36 cm
capillary using POP7 polymer (all from Applied Biosystems) and
an injection time of 23 s. PRT analyses of DEFB4 were carried out
in 366 normalized samples, as described by Armour et al. [10].
Briefly, PCR was carried out using 5 ng input genomic DNA,
0.5 mM forward primer (CCAGATGAGACCAGTGTCC) and
0.5 mM FAM-labeled reverse primer (TTTTAAGTTCAGCA-
ATTACAGC). Products were amplified using 30 cycles of 95uC
for 30 s, 53uC for 30 s and 70uC for 30 s, followed by a single
‘chase’ phase of 53uC for 1 min/70uC for 20 min. Each PCR
product was digested with 5 U of Hae III (New England Biolabs)
and analyzed by electrophoresis, as above.
Data analysis
The efficiency of the qPCR assays for PRELID1, SYNPO,
DEFB4 and the endogenous control RNase P was calculated using
the formula: E=10
(21/m)-1, where m is the slope of the function
derived from the Ct versus log-dilution plot (0.02–200 ng input DNA)
of a DNA sample. Analyses of qPCR data were performed using
the maximum likelihood method available in Copy Caller v1.0
software (Applied Biosystems), which calculates the probability
that the observed data point represents a discrete integer value.
These calculations are based solely on DCt values, and therefore
are highly dependent on target and endogenous control assay
efficiencies. Correlation between the starting amount of DNA and
Copy Caller-estimated copy number values was calculated using
the online tools available at http://danielsoper.com/statcalc3/. In
the PRT experiments, a maximum likelihood approach was also
used to estimate the copy number values from peak area ratios
(target/paralog). In all cases, calculations were performed taking
into account that the modal copy numbers of PRELID1, SYNPO
and the b-defensin gene cluster are 2, 2 and 4 [5], respectively. In
order to establish the reproducibility of both qPCR and PRT, the
analyses of DEFB4 were repeated twice in the 366 normalized
samples and replicate copy number predictions for each sample
were compared.
Results and Discussion
Copy number assignment by qPCR is affected by input
DNA amount
All qPCR amplification plots constructed over a four-log
dilution-range of input DNA fitted a straight line (R
2.0.99).
Amplification efficiencies of the PRELID1 and SYNPO assays were
108.23% and 97.84%, respectively, and absolute efficiency
differences between each target gene and the internal control
(RNase P) were 5.95% and 4.42%, respectively (Figure S1).
PRELID1 and SYNPO genes were analyzed by qPCR in 400
normalized and 400 non-normalized DNA samples. Calculated
qPCR and PRT for CNV Analysis
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normal distribution that was tightly clustered around 2 copies in
the normalized sample cohort. Clustering was less compact in the
randomly diluted DNA sample set, where values markedly spread
away from the central value, so that gene copy numbers
apparently ranged from 1 to 3, for both PRELID1 and SYNPO
(Figure 2). In the case of PRELID1, there was a significant trend
(R=0.3932; p=0.0196) towards higher copy number assignments
for samples with DNA input amounts above the average
(13.28 ng; range 2–120 ng) of the sample set (Figure 3), even
after removing outliers (.75 ng input DNA).
Due to the simplicity of its experimental design, qPCR is
routinely used for the relative quantitation of mRNA in gene
expression analyses, and the same rationale has been transferred to
the study of gene copy number variation. However, results
obtained with qPCR have not always been robust, and association
studies of CNVs with complex human diseases have been
conflicting. In fact, the method employed to extract the raw data
for copy number determinations relies on calculations based solely
on DCt values, and assumes that all amplification efficiencies are
equal to 100%, or at least equal between the two reactions (target
gene and reference sequence) that are simultaneously performed in
Figure 1. Schematic representation of the PRT assay for PRELID1. Forward and FAM-labeled reverse primers amplify two 299 bp fragments
from different genomic locations (PRELID1, the target gene on chromosome 5 and a paralog on chromosome 1). Bcl I digestion results in a 169 bp
labeled fragment in the paralog amplicon, which can be distinguished from the undigested PRELID1 fragment by fluorescent capillary
electrophoresis. Coordinates correspond to GRCh37/hg19 genome assembly.
doi:10.1371/journal.pone.0028910.g001
Figure 2. Distribution of PRELID1 and SYNPO calculated copy numbers in normalized (black bars) and randomly diluted (gray bars)
DNA samples using qPCR. Samples falling into the light gray areas are predicted to have two copies of the gene.
doi:10.1371/journal.pone.0028910.g002
qPCR and PRT for CNV Analysis
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between the two assays used in a qPCR experiment is directly
proportional to the difference in the slopes of the serial dilution
curves (Figure S1). This difference implies that the distance
between the two lines will change as a function of input DNA
amount, resulting in proportional changes of DCt, and thus of
calculated copy numbers.
On the other hand, since PRT uses the same pair of primers for
the amplification of both target and paralog sequences, potential
differences in amplification efficiency depend only on amplicon
Figure 3. Correlation between the amount of input DNA per qPCR reaction and the raw copy number values for PRELID1.
doi:10.1371/journal.pone.0028910.g003
Figure 4. Influence of DNA integrity on PRELID1 copy number assignment by qPCR and PRT analysis. Distribution of calculated copy
number values (black bars) and frequency of predicted copy numbers (gray bars) in a) high quality and b) degraded DNA samples, and gel
electrophoresis of a subset of each sample set. Lanes 1 and 2 correspond to DNA size markers (l-HindIII and 123 bp ladder) and 3–10 to genomic
DNA samples. The size of several marker bands is shown in base pairs. The distribution of predicted copy number values differ significantly between
good quality and degraded samples in the PRT analysis (x
2=38.34; p=2?10
28) and between qPCR and PRT copy number assignments in degraded
DNA samples (x
2=33.96; p=2?10
27).
doi:10.1371/journal.pone.0028910.g004
qPCR and PRT for CNV Analysis
PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e28910structure and sequence, and can generally be obviated if amplicons
with quasi-identical sequences are selected (as in the case of
PRELID1). However, in those cases when length and/or structure
of the amplicons differ considerably, attention should be paid to
the input DNA amounts for the PCR reactions, in order to avoid
inaccuracies in copy number calling.
In a recent study addressing CNV analysis of the b-defensin
gene cluster, the qPCR approach was reported to be very
sensitive to the quality of template DNA, generating systematic
biases that could produce false disease association evidences.
However, the authors omitted a crucial issue for robust copy
number value assessment because they focused only on template
quality, and used a very wide range of starting DNA amounts
(10–75 ng per reaction), although differences in efficiency
between target and reference genes were close to 5% [16].
Moreover, the authors did not mention which quality factors
could be modifying copy number value assignments, and did not
provide any evidence to support the importance of DNA quality
for copy number analyses by qPCR. On the other hand, in a
previous study, it was shown that sample dilution and inhibitor
content (such as salts or competing DNA), did not significantly
affect amplification efficiency, so that most of its variability relied
on primer and amplicon structures and sequences [17]. In our
study, we have shown that when the difference in efficiency is
between 4 and 6%, variations in input DNA amount can modify
DCt values and possibly provide false copy number values in
PRELID1 and SYNPO (both genes with modal copy numbers of
2). In the case of genes with higher modal copy numbers, this
effect would be amplified making calculations more prone to
error.
Differences in amplification efficiencies between target and
reference amplicons are the biggest challenge to deal with in
qPCR optimization for CNV analysis, because they are
responsible for variations in DCt that can result in artifactual
copy number assignments when a wide range of input DNA
amounts is used. Our results show that deviation from the
average input DNA amount strongly affects final copy number
calculations, but that accurate DNA normalization can, at least in
part, overcome this problem. Since gene copy numbers are
integers, calculated copy number values based on DCt results are
expected to cluster around discrete figures, and this is best
achieved using normalized DNA samples, as observed in this
study. If DNA concentrations are normalized, reliable qPCR-
based CNV analyses of different genes can be performed using
Figure 5. Distribution of calculated copy number values for DEFB4 obtained with qPCR and PRT in 366 normalized, high quality
DNA samples.
doi:10.1371/journal.pone.0028910.g005
qPCR and PRT for CNV Analysis
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designed only for each of the target genes of interest or might
even be commercially available.
PRT assays are very sensitive to DNA degradation
The distribution of calculated PRELID1 copy numbers using the
PRTtechniqueshowed a tight Gaussiandistribution ingood quality
DNA samples, but in contrast, degraded DNA samples presented
marked spreading over a wider range (,1-.3 copy numbers) and
did not resemble a normal distribution (Figure 4). PRT has proven
to be a robust technique for CNV assignment, but optimal results
can be obtained only when high quality DNA samples are used. In
turn,DNAdegradationdoes not seemtoaffectqPCR(Figure 4)and
we hypothesize that this lower impact is not caused by any
technique-specific condition or characteristic, but could be due to
amplicon length, much shorter in the case of the qPCR specific
assays compared to PRT assays. PRELID1 and DEFB4 amplicon
lengths are 107 bp and 127 bp for qPCR and 299 bp and 443 bp
for PRT, respectively. The experimental setup of a PRT assay is
indeed complicated, because one must design a pair of primers that
will amplify two (and not more) genomic stretches of DNA, and this
will determine the length of the amplicon. A longer genomic
fragment will be repeated less frequently throughout the genome
and thus is expected to be more specific, but longer PCR
amplifications have been shown to be more sensitive to template
DNA degradation [18]. Moreover, as in the case of SYNPO,t h e
design of a PRT assay is not always possible, because suitable
paralogs are not found for every genomic sequence.
Figure 7. Bland-Altman plot showing deviation of DEFB4 calculated copy number values obtained by PRT, compared to qPCR.
doi:10.1371/journal.pone.0028910.g007
Figure 6. Correlation of calculated DEFB4 copy number values between replicates in qPCR (R=0.8546) and PRT (R=0.8193)
techniques.
doi:10.1371/journal.pone.0028910.g006
qPCR and PRT for CNV Analysis
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conditions
DEFB4 gene copy number was analyzed in 366 high quality,
normalized DNA samples by both qPCR (absolute efficiency
difference with RNase P=7.36%) and PRT and showed a similar
distribution of calculated copy numbers, with values clustering
around discrete figures (Figure 5). On the other hand, qPCR in
triplicate and PRT showed similar standards of reproducibility,
and calculated copy numbers showed strong correlation among
replicates in both qPCR and PRT (Figure 6). Concordance rates
of predicted copy numbers between replicates were 66% and 65%,
for qPCR and PRT, respectively. Comparison of the results
obtained with the two different techniques also showed a very
significant correlation (R=0.7956) and differences in calculated
copy numbers were below 1 in 83% of the samples (Figure 7).
Concordance in predicted copy numbers is shown in Table 1; 62%
of samples showed the same predicted copy number with both
qPCR and PRT, whereas 23% showed a higher copy number
prediction with qPCR, and the rest of the sample set (15%) had a
lower copy number assignment when analyzed with qPCR.
In brief, our study emphasizes and provides evidence on the
extreme importance of DNA normalization when assigning copy
number values by qPCR, because this method is sensitive to
differences in amplification efficiencies between the target and
control assays, and on the relevance of DNA quality when using
PRT, due to the fact that longer amplicons are usually needed to
optimize sensitivity and specificity, as had already been suggested
by other authors [19], especially in large population screenings
where the risk for false positive associations is high. Both
techniques can be further optimized by analyzing the CNV region
more deeply, with the use of multiple primer-probe sets in the case
of qPCR [8] or increasing the number of replicates and/or paralog
pairs when using PRT [16] to ensure accurate copy number
assignment. Under optimal conditions of DNA normalization and
quality, both techniques are nearly as comparable between them
as they are when compared to their own replicates, and are valid
alternatives for population-scale CNV studies.
Supporting Information
Figure S1 Amplification efficiency plots for Taqman Copy
Number assay pairs (target and reference) calculated from
multiplex reactions with input DNA concentrations covering 4
orders of magnitude (0.02–200 ng DNA) per reaction.
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